Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Uterine Transposition: Feasibility Study

NCT03040921 is registered in ClinicalTrials.gov with Hospital Erasto Gaertner as lead sponsor.

NCT NCT03040921
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03040921 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Uterine Transposition: Feasibility Study
Lead sponsor
Hospital Erasto Gaertner
Phase
Not applicable
Overall status
Completed
Start date
June 1, 2017
Completion date
April 1, 2021
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

intraoperative complications, ovarian failure, postoperative complications, tissue damage, uterus disorder